A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV Infection

BACKGROUND & AIMS: Polymorphisms in the interleukin-28B (IL28B) gene are associated with outcomes from infection with hepatitis C virus (HCV). However, the role of these polymorphisms in protecting injection drug users who are at high risk for HCV infection but do not have detectable antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Knapp, Susanne, Warshow, Usama, Ho, K.M. Alexander, Hegazy, Doha, Little, Ann–Margaret, Fowell, Andrew, Alexander, Graeme, Thursz, Mark, Cramp, Matthew, Khakoo, Salim I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194089/
https://www.ncbi.nlm.nih.gov/pubmed/21600205
http://dx.doi.org/10.1053/j.gastro.2011.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194089/
https://www.ncbi.nlm.nih.gov/pubmed/21600205
http://dx.doi.org/10.1053/j.gastro.2011.04.005

Ejemplares similares